Valérie Boige

Inserm — France

Medicine · Health Sciences

83h-index36.2kcitations508works13.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(210), Hepatocellular Carcinoma Treatment and Prognosis(143), Gastric Cancer Management and Outcomes(88), Cancer Treatment and Pharmacology(77), Pancreatic and Hepatic Oncology Research(69)

Publications506 total

A predictive model for life-threatening fluoropyrimidine toxicity based on <i>DPYD</i> sequencing in colorectal cancer
JNCI Journal of the National Cancer Institute·2025
Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30/PRODIGE 53 (NCT03164655)
Annals of Surgical Oncology·2025· 1 cited
Real-world immunotherapy outcomes in unresectable peritoneal mesothelioma: A French experience
European Journal of Cancer·2025
Heads or tails? In-depth analysis of pancreatic cancer outcome according to tumor location
ESMO Gastrointestinal Oncology·2025Open Access
Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis
Annals of Surgical Oncology·2025· 2 cited
ASO Visual Abstract: Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis
Annals of Surgical Oncology·2025· 1 cited
747P Regorafenib plus Irinotecan versus regorafenib alone in metastatic colorectal cancer after standard therapies failure in cyclin D1 A/A(870) genotype patients: The randomised phase III NEXT-REGIRI trial
Annals of Oncology·2025
2268eP Integrating tumor volumetry and liquid biopsy: A new model to define prognosis in advanced pancreatic ductal adenocarcinoma
Annals of Oncology·2025Open Access
2265eP Does diagnostic delay matter? A survival analysis in pancreatic cancer
Annals of Oncology·2025
Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: the RASINTRO prospective multicenter study
JNCI Journal of the National Cancer Institute·2025
48P Impact of the KRAS mutation subtype on treatment response in metastatic colorectal cancer
Annals of Oncology·2025Open Access
75P Clinical and molecular characteristics of young onset colorectal cancers
Annals of Oncology·2025· 1 citedOpen Access
292P Long survival in metastatic pancreatic cancer: Clinical and biological predictors from a large retrospective cohort
Annals of Oncology·2025Open Access
57P Hepatic arterial infusion with mitomycin C in patients with colorectal liver metastases
Annals of Oncology·2025
12P ORGANOTREAT-01: A pioneer phase I/II multicenter trial of organoid-driven precision medicine for refractory colorectal cancer
Annals of Oncology·2025· 1 citedOpen Access
IMMUNORARE <sup>5</sup> : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Peritoneal Mesotheliomas Cohort.
Journal of Clinical Oncology·2025
What are the outcomes for long-term survivors after esophagectomy ? – Evidence from a randomized controlled trial (FFCD9901)
European Journal of Surgical Oncology·2025· 2 citedOpen Access
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients
Future Oncology·2025· 1 citedOpen Access
EORTC-1203 GITC "INNOVATION": Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy of HER-2 positive stomach cancer: Overall survival results.
Journal of Clinical Oncology·2025· 8 cited
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
Annals of Oncology·2024· 30 citedOpen Access
page 1 of 26Next →

Frequent Co-authors

Michel Ducreux(31), David Malka(12), Thierry de Baère(12), Clarisse Dromain(11), Olivier Bouché(10), Pierre Laurent‐Puig(9), P Lasser(9), Jean‐Pierre Pignon(7), Dominique Élias(7), Dominique Elias(7), Marc Ychou(6), Thierry Conroy(6), Christophe Borg(6), Diane Goèré(6), Christophe Louvet(5), Pierre-Luc Etienne(5), Éric Baudin(5), Jean‐Baptiste Bachet(4), Delphine Le Corre(4), Bruno Landi(4)